These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


308 related items for PubMed ID: 17487784

  • 1. Cancer vaccines: challenges and outlook in the field.
    Paul S, Acres B, Limacher JM, Bonnefoy JY.
    IDrugs; 2007 May; 10(5):324-8. PubMed ID: 17487784
    [Abstract] [Full Text] [Related]

  • 2. Therapeutic cancer vaccines.
    Acres B, Paul S, Haegel-Kronenberger H, Calmels B, Squiban P.
    Curr Opin Mol Ther; 2004 Feb; 6(1):40-7. PubMed ID: 15011780
    [Abstract] [Full Text] [Related]

  • 3. Ampligen: a potential toll-like 3 receptor adjuvant for immunotherapy of cancer.
    Jasani B, Navabi H, Adams M.
    Vaccine; 2009 May 26; 27(25-26):3401-4. PubMed ID: 19200817
    [Abstract] [Full Text] [Related]

  • 4. A paradigm shift in therapeutic vaccination of cancer patients: the need to apply therapeutic vaccination strategies in the preventive setting.
    Gray A, Raff AB, Chiriva-Internati M, Chen SY, Kast WM.
    Immunol Rev; 2008 Apr 26; 222():316-27. PubMed ID: 18364011
    [Abstract] [Full Text] [Related]

  • 5. DNA vaccines: precision tools for activating effective immunity against cancer.
    Rice J, Ottensmeier CH, Stevenson FK.
    Nat Rev Cancer; 2008 Feb 26; 8(2):108-20. PubMed ID: 18219306
    [Abstract] [Full Text] [Related]

  • 6. Roadmap to a better therapeutic tumor vaccine.
    Emens LA.
    Int Rev Immunol; 2006 Feb 26; 25(5-6):415-43. PubMed ID: 17169782
    [Abstract] [Full Text] [Related]

  • 7. Synthetic peptides as cancer vaccines.
    Sundaram R, Dakappagari NK, Kaumaya PT.
    Biopolymers; 2002 Feb 26; 66(3):200-16. PubMed ID: 12385038
    [Abstract] [Full Text] [Related]

  • 8. Cancer vaccines: preclinical studies and novel strategies.
    Palena C, Abrams SI, Schlom J, Hodge JW.
    Adv Cancer Res; 2006 Feb 26; 95():115-45. PubMed ID: 16860657
    [Abstract] [Full Text] [Related]

  • 9. Rational peptide-based tumour vaccine development and T cell monitoring.
    Scheibenbogen C, Letsch A, Schmittel A, Asemissen AM, Thiel E, Keilholz U.
    Semin Cancer Biol; 2003 Dec 26; 13(6):423-9. PubMed ID: 15001161
    [Abstract] [Full Text] [Related]

  • 10. Cancer vaccination.
    Del Vecchio M, Parmiani G.
    Forum (Genova); 1999 Dec 26; 9(3):239-56. PubMed ID: 10504171
    [Abstract] [Full Text] [Related]

  • 11. Immunology and breast cancer: therapeutic cancer vaccines.
    Curigliano G, Rescigno M, Goldhirsch A.
    Breast; 2007 Dec 26; 16 Suppl 2():S20-6. PubMed ID: 17706425
    [Abstract] [Full Text] [Related]

  • 12. Promises and limitations of murine models in the development of anticancer T-cell vaccines.
    Lévy F, Colombetti S.
    Int Rev Immunol; 2006 Dec 26; 25(5-6):269-95. PubMed ID: 17169777
    [Abstract] [Full Text] [Related]

  • 13. Therapeutic cancer vaccines.
    Morris LF, Ribas A.
    Surg Oncol Clin N Am; 2007 Oct 26; 16(4):819-31, ix. PubMed ID: 18022546
    [Abstract] [Full Text] [Related]

  • 14. DNA vaccines: successes and limitations in cancer and infectious disease.
    Lowe DB, Shearer MH, Kennedy RC.
    J Cell Biochem; 2006 May 15; 98(2):235-42. PubMed ID: 16440328
    [Abstract] [Full Text] [Related]

  • 15. Whole-cell vaccines: A failure or a success waiting to happen?
    Copier J, Dalgleish A.
    Curr Opin Mol Ther; 2010 Feb 15; 12(1):14-20. PubMed ID: 20140812
    [Abstract] [Full Text] [Related]

  • 16. Designer adjuvants for enhancing the efficacy of infectious disease and cancer vaccines based on suppression of regulatory T cell induction.
    Mills KH.
    Immunol Lett; 2009 Feb 21; 122(2):108-11. PubMed ID: 19100777
    [Abstract] [Full Text] [Related]

  • 17. Towards therapeutic vaccines for colorectal carcinoma: a review of clinical trials.
    Mosolits S, Nilsson B, Mellstedt H.
    Expert Rev Vaccines; 2005 Jun 21; 4(3):329-50. PubMed ID: 16026248
    [Abstract] [Full Text] [Related]

  • 18. Cancer vaccines for established cancer: how to make them better?
    Andrews DM, Maraskovsky E, Smyth MJ.
    Immunol Rev; 2008 Apr 21; 222():242-55. PubMed ID: 18364006
    [Abstract] [Full Text] [Related]

  • 19. Clinical results of vaccine therapy for cancer: learning from history for improving the future.
    Choudhury A, Mosolits S, Kokhaei P, Hansson L, Palma M, Mellstedt H.
    Adv Cancer Res; 2006 Apr 21; 95():147-202. PubMed ID: 16860658
    [Abstract] [Full Text] [Related]

  • 20. [Cancer vaccines].
    Kyte JA.
    Tidsskr Nor Laegeforen; 2006 Nov 16; 126(22):2969-73. PubMed ID: 17117197
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.